Outcome title | Number of study arms | Number of patients on AE | Effect sizea | Test for overall effect, Pvalue | Heterogeneity, I2; Ï„2 (%) |
---|---|---|---|---|---|
Type of exercise | Â | Â | Â | Â | Â |
   Land-based | 22 | 463 | -0.29 (-0.46,-0.13) | 0.0005 | 27; 0.03 |
   Water-based | 3 | 61 | -0.67 (-1.04,-0.29) | 0.0005 | 0; 0 |
   Mixed | 4 | 43 | -0.03 (-0.45,0.39) | 0.89 | 0; 0 |
Type of exercise | Â | Â | Â | Â | Â |
   AE only | 12 | 273 | -0.35 (-0.61,-0.09) | 0.0008 | 48; 0.09 |
   AE combined with other exercise | 17 | 294 | -0.28 (-0.45,-0.15) | 0.001 | 0; 0 |
Duration of study | Â | Â | Â | Â | Â |
   <7 weeks | 2 | 32 | -1.16 (-1.86,-0.48) | 0.001 | 36; 0.09 |
   7 to 12 weeks | 13 | 194 | -0.24 (-0.50,-0.02) | 0.03 | 16; 0.02 |
   >12 weeks | 12 | 338 | -0.24 (-0.40,-0.08) | 0.004 | 0; 0 |
Frequency of training/week | Â | Â | Â | Â | Â |
   1 time/week | 2 | 37 | -0.07 (-0.54,03.9) | 0.48 | Not applicable |
   2 times/week | 5 | 127 | -0.69 (-0.95,-0.27) | 0.0004 | 35; 0.06 |
   3 times/week | 16 | 241 | -0.35 (-0.62,-0.09) | 0.009 | 48; 0.10 |
   >3 times/week | 4 | 142 | -0.13 (-0.38, 0.13) | 0.33 | 2; 0 |
Total duration aerobic exerciseb | Â | Â | Â | Â | Â |
   <1,000 minutes | 10 | 175 | -0.47 (-0.86,-0.08) | 0.02 | 62; 0.19 |
   1,000 to 2,000 minutes | 9 | 175 | -0.36 (-0.59,-0.13) | 0.002 | 0; 0 |
   >2,000 minutes | 8 | 217 | -0.15 (-0.34, 0.05) | 0.15 | 0; 0 |
Intensity of AEc | Â | Â | Â | Â | Â |
   <50% maxHR | 1 | 37 | -0.09 (-0.54, 0.36) | Not applicable | Not applicable |
   Left up to patient | 2 | 79 | -0.42 (-0.77, -0.07) | 0.02 | 0; 0 |
   > 50% maxHR | 21 | 367 | -0.26 (-0.42,-0.11) | 0.0007 | 0; 0 |
Type of control group | Â | Â | Â | Â | Â |
   Attention placebo | 7 | 229 | -0.27 (-0.62, 0.07) | 0.12 | 67; 0.12 |
   Therapy as usual | 10 | 147 | -0.47 (-0.71,-0.24) | <0.0001 | 0; 0 |
   Active therapy | 10 | 191 | -0.27 (-0.49,-0.06) | 0.01 | 0; 0 |